• Access To Medicines

Influencing and shaping our sector BIA update: October 2023 - January 2024

An overview of the BIA's influencing work on behalf of the innovative life science and biotech sector between October 2023 and January 2024.

BIA response to NICE TA-HST charging review

Evaluating patient access to rare disease treatments

Influencing and shaping our sector BIA update: July - October 2023

The BioIndustry Association (BIA) continued to represent the innovative life science and biotech sector to Ministers and senior policymakers between July and October 2023.

BIA response to DHSC statutory scheme consultation

The BIA has responded to DHSC's consultation on the proposed review of the statutory scheme to control the cost of branded health service medicines. 

mRNA Revolution: A new generation of medicine

mRNA Revolution: A New Generation of Medicine explains how the UK will lead the way in developing and delivering next-generation mRNA medicines for a wide range of diseases, beyond just COVID-19.

BIA response to consultation on antimicrobial subscription model

Influencing and shaping our sector BIA update: April - July 2023

Making VPAS fit for the future: the BIA vision